Cart
sales@molnova.com
Y06036
CAS No. 1832671-96-1
Y06036 ( —— )
Catalog No. M20086 CAS No. 1832671-96-1
Y06036 a potent and selective BET inhibitor can bind to the BRD4(1) bromodomain (Kd: 82 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 110 | In Stock |
|
| 50MG | 178 | In Stock |
|
| 100MG | 332 | In Stock |
|
| 500MG | 782 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameY06036
-
NoteResearch use only not for human use.
-
Brief DescriptionY06036 a potent and selective BET inhibitor can bind to the BRD4(1) bromodomain (Kd: 82 nM).
-
DescriptionY06036 a potent and selective BET inhibitor can bind to the BRD4(1) bromodomain (Kd: 82 nM).
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorBRD4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1832671-96-1
-
Formula Weight427.27
-
Molecular FormulaC16H15BrN2O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL (234 mM)
-
SMILESCOc1ccc(Br)cc1S(=O)(=O)Nc1cc2c(C)noc2cc1OC
-
Chemical Name5-Bromo-2-methoxy-N-(6-methoxy-3-methylbenzo[d]-isoxazol-5-yl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang M et al. Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC). J Med Chem. 2018 Apr 12;61(7):3037-3058.
molnova catalog
related products
-
ZL0580
ZL0580 induces HIV suppression by inhibiting Tat transactivation and transcription elongation as well as by inducing repressive chromatin structure at the HIV promoter.
-
Y06036
Y06036 a potent and selective BET inhibitor can bind to the BRD4(1) bromodomain (Kd: 82 nM).
-
UNC926 hydrochloride
UNC926 hydrochloride is a?methyl-lysine (Kme) reader domain?inhibitor.
